All Stories

  1. A comparative analysis of age of onset and associated factors in non-refugee immigrants versus native-born individuals with psychotic disorders
  2. EMDR therapy vs. supportive therapy as adjunctive treatment in trauma-exposed bipolar patients: A randomised controlled trial
  3. The impact of sex in the effectiveness of functional remediation in bipolar disorder
  4. Barriers and facilitators to implementing workplace interventions to promote mental health: qualitative evidence synthesis
  5. The effects of different types of organisational workplace mental health interventions on mental health and wellbeing in healthcare workers: a systematic review
  6. Comparison of male and female non-refugee immigrants with psychosis: clinical, sociodemographic, and migration-related differences and impact on stress
  7. Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries
  8. Adverse childhood experiences and clinical effects of transcranial direct current stimulation in major depressive disorder: Results from the DepressionDC trial
  9. Suicidal behaviors and adverse childhood experiences: A cross-diagnostic study in persistent depressive disorder and borderline personality disorder
  10. Transdiagnostic analysis of adverse childhood experiences and their association with psychopathology–A TRANS-D conform study
  11. Effects of resilience and timing of adverse and adaptive experiences on interpersonal behavior: a transdiagnostic study in a clinical sample
  12. A comparison of PTSD and traumatic event rates in a clinical sample of non-refugee immigrants and native-born individuals with a psychotic disorder: a case-control study
  13. Correction: Outcome assessment of a complex mental health intervention in the workplace. Results from the MENTUPP pilot study
  14. Implementation and evaluation of a multi-level mental health promotion intervention for the workplace (MENTUPP): study protocol for a cluster randomised controlled trial
  15. Promoting employee wellbeing and preventing non-clinical mental health problems in the workplace: a preparatory consultation survey
  16. Loneliness is associated with retrospective self-reports of adverse childhood experiences – A replication study in Ethiopia
  17. Outcome assessment of a complex mental health intervention in the workplace. Results from the MENTUPP pilot study
  18. EMDR therapy vs. Supportive Therapy as adjunctive treatment in trauma-exposed bipolar patients: a randomized controlled trial.
  19. Developing a framework for evaluation: a Theory of Change for complex workplace mental health interventions
  20. A systematic review of digital interventions for smoking cessation in patients with serious mental illness
  21. Evidence for the effectiveness of interventions to reduce mental health related stigma in the workplace: a systematic review
  22. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study
  23. Prevalence of clozapine-induced sialorrhea and its effect on quality of life
  24. Prevalence and Characterization of Psychological Trauma in Patients with Fibromyalgia: A Cross-Sectional Study
  25. The effectiveness of organisational-level workplace mental health interventions on mental health and wellbeing in construction workers: A systematic review and recommended research agenda
  26. Corrigendum to “Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population” [J. Affect. Disord. 249 (2019) 199–207 (Apr 15)]
  27. High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample
  28. Psychological trauma as a transdiagnostic risk factor for mental disorder: an umbrella meta-analysis
  29. Suicidal behaviors are associated with loneliness and decrease during inpatient CBASP treatment for persistent depressive disorder
  30. A fair day's wage for a fair day's work
  31. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic
  32. Workplace interventions to reduce depression and anxiety in small and medium-sized enterprises: A systematic review
  33. Clinical Features, Neuropsychology and Neuroimaging in Bipolar and Borderline Personality Disorder: A Systematic Review of Cross-Diagnostic Studies
  34. Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder
  35. The Prevalence and Clinical and Sociodemographic Factors of Problem Online Gambling: A Systematic Review
  36. Augmentation of EMDR with multifocal transcranial current stimulation (MtCS) in the treatment of fibromyalgia: study protocol of a double-blind randomized controlled exploratory and pragmatic trial
  37. Evidence for implementation of interventions to promote mental health in the workplace: a systematic scoping review protocol
  38. Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic
  39. Evidence for Implementation of Interventions to Promote Mental Health in the Workplace: A Systematic Scoping Review Protocol
  40. EMDR Versus Treatment-as-Usual in Patients With Chronic Non-Malignant Pain: A Randomized Controlled Pilot Study
  41. Traumatic Events in Dual Disorders: Prevalence and Clinical Characteristics
  42. Corrigendum: A Multicenter Phase II RCT to Compare the Effectiveness of EMDR Versus TAU in Patients With a First-Episode Psychosis and Psychological Trauma: A Protocol Design
  43. A Multicenter Phase II RCT to Compare the Effectiveness of EMDR Versus TAU in Patients With a First-Episode Psychosis and Psychological Trauma: A Protocol Design
  44. The Current Status of EMDR Therapy Involving the Treatment of Complex Posttraumatic Stress Disorder
  45. The Status of EMDR Therapy in the Treatment of Posttraumatic Stress Disorder 30 Years After Its Introduction
  46. Theoretical Background and Clinical Aspects of the Use of EMDR in Patients With Bipolar Disorder
  47. Editorial: Present and Future of EMDR in Clinical Psychology and Psychotherapy
  48. A 12-month prospective study on the time to hospitalization and clinical management of a cohort of bipolar type I and schizoaffective bipolar patients
  49. Spanish validation of the Barcelona TEMPS-A questionnaire in patients with bipolar disorder and general population
  50. A Multicenter Phase II Rater-Blinded Randomized Controlled Trial to Compare the Effectiveness of Eye Movement Desensitization Reprocessing Therapy vs. Treatment as Usual in Patients With Substance Use Disorder and History of Psychological Trauma: A Stu...
  51. That which does not kill you-May afflict you? Psychological trauma in bipolar disorder
  52. Meta-analyses of cavum septum pellucidum in mood disorders in comparison with healthy controls or schizophrenia
  53. Cognitive Remediation Interventions in Schizoaffective Disorder: A Systematic Review
  54. How Does Eye Movement Desensitization and Reprocessing Therapy Work? A Systematic Review on Suggested Mechanisms of Action
  55. A Non-randomized Controlled Trial of EMDR on Affective Symptoms in Patients With Glioblastoma Multiforme
  56. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables
  57. Multimodal Brain Changes in First-Episode Mania: A Voxel-Based Morphometry, Functional Magnetic Resonance Imaging, and Connectivity Study
  58. Eye Movement Desensitization and Reprocessing and Slow Wave Sleep: A Putative Mechanism of Action
  59. Efficacy of Eye Movement Desensitization and Reprocessing in Children and Adolescent with Post-traumatic Stress Disorder: A Meta-Analysis of Randomized Controlled Trials
  60. EMDR beyond PTSD: A Systematic Literature Review
  61. Efficacy of quetiapine XR vs. placebo as concomitant treatment to mood stabilizers in the control of subthreshold symptoms of bipolar disorder: Results from a pilot, randomized controlled trial
  62. Impact of childhood trauma on cognitive profile in bipolar disorder
  63. Psychiatric and physical comorbidities and their impact on the course of bipolar disorder: A prospective, naturalistic 4-year follow-up study
  64. Evaluation of machine learning algorithms and structural features for optimal MRI-based diagnostic prediction in psychosis
  65. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial
  66. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study
  67. Meta-Analysis of the Risk of Subsequent Mood Episodes in Bipolar Disorder
  68. Structural and Functional Brain Correlates of Cognitive Impairment in Euthymic Patients with Bipolar Disorder
  69. Surface-based brain morphometry and diffusion tensor imaging in schizoaffective disorder
  70. Brain functional changes in first-degree relatives of patients with bipolar disorder: evidence for default mode network dysfunction
  71. Neuropsychological and neuroimaging underpinnings of schizoaffective disorder: a systematic review
  72. 25 años de Eye Movement Desensitization and Reprocessing: protocolo de aplicación, hipótesis de funcionamiento y revisión sistemática de su eficacia en el trastorno por estrés postraumático
  73. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome
  74. Cognitive reserve in bipolar disorder: relation to cognition, psychosocial functioning and quality of life
  75. Prevalence of cavum vergae in psychosis and mood spectrum disorders
  76. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory
  77. Midline Brain Abnormalities Across Psychotic and Mood Disorders
  78. Brain structural changes in schizoaffective disorder compared to schizophrenia and bipolar disorder
  79. Prevalence and impact of comorbid alcohol use disorder in bipolar disorder: A prospective follow-up study
  80. Successful treatment of hydroxyzine and dexclorfeniramine maleate in combination with electroconvulsive therapy in a neuroleptic malignant catatonia
  81. Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S)
  82. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms
  83. Brain functional changes across the different phases of bipolar disorder
  84. The prevalence and effect of life events in 222 bipolar I and II patients: A prospective, naturalistic 4 year follow-up study
  85. Comparison of serum BDNF levels in deficit and nondeficit chronic schizophrenia and healthy controls
  86. Trait or state? A longitudinal neuropsychological evaluation and fMRI study in schizoaffective disorder
  87. Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: A randomized, controlled pilot-study
  88. Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM)
  89. A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients
  90. Structural Abnormalities in Schizophrenia: Further Evidence on the Key Role of the Anterior Cingulate Cortex
  91. Treatment adherence in bipolar I and schizoaffective disorder, bipolar type
  92. No effects of eye movements on the encoding of the visuospatial sketchpad and the phonological loop in healthy participants: Possible implications for eye movement desensitization and reprocessing therapy
  93. Efficacy of Functional Remediation in Bipolar Disorder: A Multicenter Randomized Controlled Study
  94. Bipolar depressed patients show both failure to activate and failure to de-activate during performance of a working memory task
  95. Differenzialdiagnostik und Psychopharmakotherapie bipolarer Störungen
  96. Deeskalationstechniken und atypische Neuroleptika in der Behandlung der akuten Manie
  97. EMDR Therapy Modulates the Default Mode Network in a Subsyndromal, Traumatized Bipolar Patient
  98. Brain functional abnormality in schizo-affective disorder: an fMRI study
  99. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls – Corrigendum
  100. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls
  101. Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients
  102. Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program
  103. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients
  104. First-episode psychosis is characterized by failure of deactivation but not by hypo- or hyperfrontality
  105. Failure of de-activation in the medial frontal cortex in mania: evidence for default mode network dysfunction in the disorder
  106. Number needed to treat analyses of drugs used for maintenance treatment of bipolar disorder
  107. Lamotrigine: when and where does it act in affective disorders? A systematic review
  108. Abnormal temperament in patients with morbid obesity seeking surgical treatment
  109. An Investigation of Temperamental Traits in Patients With Somatoform Disorder: Do They Belong in the Affective Spectrum?
  110. An Investigation of Temperamental Traits in Patients With Somatoform Disorder: Do They Belong in the Affective Spectrum?
  111. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology
  112. Predictores clínicos del funcionamiento interpersonal en pacientes bipolares
  113. Anticonvulsants in the treatment of aggression in the demented elderly: an update
  114. Weight gain in bipolar disorder: pharmacological treatment as a contributing factor
  115. Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration?
  116. Myoclonus Provoked by Lamotrigine in a Bipolar Patient
  117. Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects
  118. Antiepileptic Drugs and Mood Stability
  119. A 2-Year, Open-Label Pilot Study of Adjunctive Chromium in Patients With Treatment-Resistant Rapid-Cycling Bipolar Disorder
  120. Risperidone monotherapy in manic inpatients: An open label, multicentre trial
  121. An Exploratory Open Trial on Safety and Efficacy of the Anticonvulsant Retigabine in Acute Manic Patients
  122. Rezidivprophylaxe bipolarer Erkrankungen
  123. Zotepine loading in acute and severely manic patients: a pilot study
  124. Neurochemical Underpinnings in Bipolar Disorder and Epilepsy
  125. Antiepileptic Drugs in Mood-Disordered Patients
  126. Excitability of motor cortex inhibitory circuits in Tourette syndrome before and after single dose nicotine
  127. Caffeine has no effect on measures of cortical excitability
  128. EEG Abnormalities Under Treatment with Atypical Antipsychotics: Effects of Olanzapine and Amisulpride as Compared to Haloperidol
  129. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects
  130. The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action
  131. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design
  132. Clozapine as Add-On Medication in the Maintenance Treatment of Bipolar and Schizoaffective Disorders
  133. Clinical Relevance and Treatment Possibilities of Bipolar Rapid Cycling
  134. Klinische Relevanz und Behandlungsmöglichkeiten von Rapid Cycling bei Patienten mit bipolarer affektiver Störung
  135. Central pontine myelinolysis in a patient with anorexia nervosa
  136. Antimanic Efficacy of Topiramate in 11 Patients in an Open Trial With an On-Off-On Design
  137. Nichtletale Wirkung hochtoxischer Amitriptylin-Spiegel nach Suizidversuch
  138. Wirksamkeit, Verträglichkeit und Praktikabilität von Valproat-Miniretardtabletten bei bipolaren affektiven Störungen
  139. Dysregulation of ion fluxes in bipolar affective disorder
  140. Bupropion-induced isolated impairment of sensory trigeminal nerve function
  141. Psychopathological Changes Preceding Motor Symptoms in Huntington's Disease: A Report on Four Cases
  142. Adding Low-Dose Antidepressants to Interferon Alpha Treatment for Chronic Hepatitis C Improved Psychiatric Tolerability in a Patient with Schizoaffective Psychosis
  143. Tiagabine Appears Not to Be Efficacious in the Treatment of Acute Mania
  144. Intravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients
  145. Elektrokonvulsionstherapie in der Behandlung der schweren Manie
  146. Treatment of tardive akathisia with clonidine: a case report
  147. Female Genital Disorder as Adverse Symptom of Lamotrigine Treatment